Hyunsun Jo

Company: Pin Therapeutics

Job title: Founder & Chief Executive Officer

Seminars:

Approaches to Develop a Molecular Glue Degrader That Degrades Undruggable Transcription Factors 9:30 am

• Ternary complex formation assay • Reviewing the phenotypic screening method • Evaluating a real example for specific target proteinRead more

day: Day Two